Theriva Biologics Inc. (TOVX)
1.32
-0.01 (-0.75%)
At close: Mar 04, 2025, 3:25 PM
Theriva Biologics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 | FY94 | FY93 |
| Net Income | -18.35M | -19.68M | -14.27M | -10.12M | -15.38M | -13.42M | -15.49M | -27.8M | -44.78M | -19.78M | -12.32M | -17.07M | -7.63M | -1.71M | -3.73M | -7.21M | -9.89M | -4.1M | -1.36M | -8.62M | -9.48M | -5.76M | -17.38M | -18.6M | -9.5M | -7M | -7.4M | -6.3M | -3.9M |
| Depreciation & Amortization | 135K | 85K | 87K | 201K | 240K | 272K | 245K | 157K | 72K | 20K | 43K | 63K | 201K | 358.71K | 382.09K | 404.62K | 199.63K | 30.68K | 2.26K | -154.13K | -130.55K | -118.78K | -86.34K | -100K | -100K | -100K | n/a | n/a | -100K |
| Stock-Based Compensation | 552K | 475K | 416K | 350K | 340K | 2.07M | 3.41M | 4.01M | 3.2M | 2.46M | 1.67M | 1.85M | 1.23M | 660.65K | 323.94K | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 2.47M | -421K | 1.24M | -1.35M | -427K | -1.21M | 2.35M | 9.57M | -8.95M | 992K | 1.77M | -6K | 60K | -132.59K | -78.86K | -10.4K | 7.19K | n/a | n/a | 321.44K | -72.34K | 59.97K | 797.14K | n/a | -100K | 200K | -200K | n/a | n/a |
| Other Non-Cash Items | -2M | 2.27M | 952K | 178K | 72K | 71K | -10.74M | -11.41M | 8.16M | -620K | 425K | 8.98M | 2.9M | 70.34K | 304.41K | 739.48K | 3.08M | 1.21M | 84.51K | 622.71K | 308.14K | 444.75K | 376.13K | 300K | 2.6M | 300K | 500K | 1M | 600K |
| Deferred Income Tax | -1.64M | -1.43M | -952K | n/a | n/a | -4.08M | n/a | n/a | n/a | n/a | 942K | -188K | 377K | 247.91K | 34.4K | 357.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 2.31M | -806K | 875K | -2.78M | 855K | -2.19M | 2.37M | 7.15M | -5.54M | 1.85M | 1.52M | -2.56M | 46K | -766.35K | -232.3K | -71.33K | 7.19K | 491.96K | 186.96K | 2.32M | 1.23M | -209.07K | 951.56K | -300K | 300K | 800K | -600K | 800K | -100K |
| Operating Cash Flow | -19M | -19.08M | -12.89M | -12.17M | -13.87M | -17.28M | -20.2M | -27.9M | -38.89M | -16.08M | -7.72M | -8.92M | -2.88M | -1.14M | -2.92M | -4.85M | -6.61M | -2.37M | -1.08M | -5.82M | -8.07M | -5.65M | -16.14M | -18.7M | -6.7M | -6M | -7.5M | -4.5M | -3.5M |
| Capital Expenditures | -202K | -116K | -14K | -9K | n/a | -7K | -212K | -569K | -501K | -48K | -36K | -10K | n/a | -12.66K | -1.85K | -21.4K | -1.97M | -45.83K | n/a | -31.03K | -200.57K | -86.11K | -136.59K | -100K | -100K | -100K | n/a | n/a | n/a |
| Acquisitions | n/a | -4.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -195.52K | n/a | n/a | -665K | n/a | -154.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -417K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 421.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 249.66K | 419.67K | n/a | n/a | 200K | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -4.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 77.26K | 25.2K | 132.26K | n/a | n/a | n/a | 4.75K | n/a | n/a | 10K | 100K | n/a | -100K | n/a | -200K | n/a |
| Investing Cash Flow | -202K | -4.4M | -14K | -9K | n/a | -7K | -212K | -569K | -501K | -48K | -36K | -10K | -75K | 64.6K | -172.17K | 110.87K | -1.97M | -710.83K | n/a | -180.94K | 49.09K | 333.57K | -126.59K | -100K | 100K | -200K | n/a | -200K | n/a |
| Debt Repayment | -75K | -1.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.39K | -11.34K | -900K | 900K | 1.35M | 484.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | -288K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.71K | n/a | -579.57K | n/a | -152.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.52M | -266K | 8.04M | n/a | n/a | n/a | 12.12M | 198K | -3.32M | -1.65M | -1.03M | -680K | n/a | -114.5K | -1 | n/a | 7.55M | -1.16M | 1.75M | 5.47M | 5.84M | 4.48M | 17.69M | 20.7M | 5.2M | 6.4M | 9.3M | 3.2M | 5M |
| Financial Cash Flow | 625K | -1.93M | 74M | 3.36M | n/a | 29.09M | 18.48M | 26.71M | 42.68M | 19.03M | 12.43M | 12.2M | 6.98M | 1.01M | -50.31K | -895.61K | 7.87M | 14.11M | 2.23M | 5.47M | 5.84M | 4.48M | 17.69M | 20.7M | 5.2M | 6.4M | 9.3M | 3.2M | 5M |
| Net Cash Flow | -18.61M | -25.44M | 61.1M | -8.82M | -13.87M | 11.8M | -1.94M | -1.76M | 3.29M | 2.9M | 4.67M | 3.28M | 4.03M | -66.19K | -3.14M | -5.64M | -699.62K | 11.03M | 1.15M | -532.1K | -2.18M | -832.49K | 1.42M | 1.9M | -1.4M | 200K | 1.8M | -1.5M | 1.5M |
| Free Cash Flow | -19.2M | -19.2M | -12.9M | -12.18M | -13.87M | -17.29M | -20.42M | -28.47M | -39.39M | -16.13M | -7.75M | -8.93M | -2.88M | -1.15M | -2.92M | -4.87M | -8.57M | -2.41M | -1.08M | -5.86M | -8.27M | -5.73M | -16.28M | -18.8M | -6.8M | -6.1M | -7.5M | -4.5M | -3.5M |